Nael Hawwa1, Kevin Shrestha2, Muhammad Hammadah2, Poh Shuan Daniel Yeo3, Richard Fatica4, W H Wilson Tang5. 1. Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio. 2. Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio. 3. Apex Heart Clinic, Gleneagles Hospital, Singapore. 4. Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, Ohio. 5. Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio. Electronic address: tangw@ccf.org.
Abstract
BACKGROUND: Cardiac dysfunction influences candidate selection for kidney transplantation. There is a paucity of data regarding predictors of myocardial recovery following kidney transplantation and long-term outcomes. OBJECTIVES: The purpose of this study was to identify the extent of reverse remodeling in our kidney transplant population and the predictors of such changes, and to assess outcomes in these patients. METHODS: We reviewed 232 patients who underwent kidney transplantation at the Cleveland Clinic from 2003 to 2013 and who had baseline and post-transplant echocardiograms; patients with simultaneous heart transplantation were excluded. RESULTS: Post-transplantation mean left ventricular ejection fraction (LVEF) improved in those with LV dysfunction (increased from 41% to 50%; p < 0.0001; n = 66). There was significant improvement in other parameters, including diastolic function, LV end-diastolic dimension, LV mass, and right ventricular systolic pressure. After adjusting for multiple clinical variables, increased hemoglobin following transplantation was associated with an improved LVEF (odds ratio: 1.50; 95% confidence interval [CI]: 1.07 to 2.14; p = 0.016) and reduced mortality (hazard ratio [HR]: 0.65; 95% CI: 0.49 to 0.87; p = 0.004). An improved LVEF ≥10% predicted survival independently of a pre-transplantation LVEF (HR: 0.46; 95% CI: 0.21 to 0.93; p = 0.031). CONCLUSIONS: Kidney transplantation is associated with improved cardiac structure and function. A rise in post-transplantation hemoglobin was a significant factor associated with such changes, in addition to conferring a survival advantage.
BACKGROUND:Cardiac dysfunction influences candidate selection for kidney transplantation. There is a paucity of data regarding predictors of myocardial recovery following kidney transplantation and long-term outcomes. OBJECTIVES: The purpose of this study was to identify the extent of reverse remodeling in our kidney transplant population and the predictors of such changes, and to assess outcomes in these patients. METHODS: We reviewed 232 patients who underwent kidney transplantation at the Cleveland Clinic from 2003 to 2013 and who had baseline and post-transplant echocardiograms; patients with simultaneous heart transplantation were excluded. RESULTS: Post-transplantation mean left ventricular ejection fraction (LVEF) improved in those with LV dysfunction (increased from 41% to 50%; p < 0.0001; n = 66). There was significant improvement in other parameters, including diastolic function, LV end-diastolic dimension, LV mass, and right ventricular systolic pressure. After adjusting for multiple clinical variables, increased hemoglobin following transplantation was associated with an improved LVEF (odds ratio: 1.50; 95% confidence interval [CI]: 1.07 to 2.14; p = 0.016) and reduced mortality (hazard ratio [HR]: 0.65; 95% CI: 0.49 to 0.87; p = 0.004). An improved LVEF ≥10% predicted survival independently of a pre-transplantation LVEF (HR: 0.46; 95% CI: 0.21 to 0.93; p = 0.031). CONCLUSIONS:Kidney transplantation is associated with improved cardiac structure and function. A rise in post-transplantation hemoglobin was a significant factor associated with such changes, in addition to conferring a survival advantage.
Authors: Stefan D Anker; Josep Comin Colet; Gerasimos Filippatos; Ronnie Willenheimer; Kenneth Dickstein; Helmut Drexler; Thomas F Lüscher; Boris Bart; Waldemar Banasiak; Joanna Niegowska; Bridget-Anne Kirwan; Claudio Mori; Barbara von Eisenhart Rothe; Stuart J Pocock; Philip A Poole-Wilson; Piotr Ponikowski Journal: N Engl J Med Date: 2009-11-17 Impact factor: 91.245
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Inder Anand; John J V McMurray; James Whitmore; Marshelle Warren; Anh Pham; Mark A McCamish; Paul B J Burton Journal: Circulation Date: 2004-06-21 Impact factor: 29.690
Authors: P S Parfrey; J D Harnett; R N Foley; G M Kent; D C Murray; P E Barre; R D Guttmann Journal: Transplantation Date: 1995-11-15 Impact factor: 4.939
Authors: Nisha Bansal; Jason Roy; Hsiang-Yu Chen; Rajat Deo; Mirela Dobre; Michael J Fischer; Elyse Foster; Alan S Go; Jiang He; Martin G Keane; John W Kusek; Emile Mohler; Sankar D Navaneethan; Mahboob Rahman; Chi-Yuan Hsu Journal: Am J Kidney Dis Date: 2018-05-18 Impact factor: 8.860
Authors: M Kovářová; Z Žilinská; J Páleš; Z Kužmová; A Gažová; J Smaha; M Kužma; P Jackuliak; V Štvrtinová; J Kyselovič; J Payer Journal: Physiol Res Date: 2021-11-30 Impact factor: 1.881
Authors: Gema Miñana; Ingrid Cardells; Patricia Palau; Pau Llàcer; Lorenzo Fácila; Luis Almenar; Maria Pilar López-Lereu; Jose V Monmeneu; Martina Amiguet; Jessika González; Alicia Serrano; Vicente Montagud; Raquel López-Vilella; Ernesto Valero; Sergio García-Blas; Vicent Bodí; Rafael de la Espriella-Juan; Juan Sanchis; Francisco J Chorro; Antoni Bayés-Genís; Julio Núñez Journal: Clin Cardiol Date: 2018-06-05 Impact factor: 2.882
Authors: Luke C Pickup; Jonathan P Law; Ashwin Radhakrishnan; Anna M Price; Charalampos Loutradis; Toby O Smith; Nicola C Edwards; Richard P Steeds; Jonathan N Townend; Charles J Ferro Journal: ESC Heart Fail Date: 2021-03-15